EQPT

EquipmentShare.com Inc.

58
Fundamentals57/ 100
Valuation50/ 100
Upside potential63/ 100
Risk potential40/ 100

EQPT has a slight edge over RKLB overall, supported by lower modeled downside.

RKLB

Rocket Lab USA, Inc.

56
Fundamentals66/ 100
Valuation50/ 100
Upside potential66/ 100
Risk potential46/ 100

RKLB offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.

EQPT Fundamentals

MetricStatus
Strong
Healthy
Under pressure
Weak

EQPT's revenue and profitability are currently healthy, but its cash flow and balance sheet are under pressure.

RKLB Fundamentals

MetricStatus
Strong
Under pressure
Weak
Unavailable

RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.

EQPT PE Valuation

LevelPEPriceVs current
Forward21x$15.43—
Current108x$15.43—
Cheap167x$23.43+52%
Fair210x$29.38+90%
Expensive228x$31.95+107%

Historical ranges are pointers, not guarantees.

EQPT's PE is 108x, but its earnings don't support one, so it isn't a reliable read right now.

RKLB PE Valuation

RKLB has no meaningful PE right now: it lost money over the past year.

EQPT Forward outlook

MetricOutlook
Strongly improving
Returning to profit
Strong growth
Strongly improving
Limited
Low

Analysts expect EQPT to return to profit, with revenue growing. However, they disagree widely on these estimates.

RKLB Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
Low

Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

EQPT Risk to reward

ScenarioChangePrice
Upside+69%$26.07
Downside-40%$9.26

Calculated from the latest close: $15.43 on Nov 12.

EQPT trails RKLB on modeled risk to reward, with less potential upside relative to its potential downside.

RKLB Risk to reward

ScenarioChangePrice
Upside+88%$120.71
Downside-46%$34.64

Calculated from the latest close: $64.07 on Nov 12.

RKLB has a better modeled risk to reward balance than EQPT, with more potential upside relative to its potential downside.

EQPT Earnings Per Share

Q2 2025: $-0.11Q3 2025: $-0.09Q4 2025: $-0.03Q1 2026: $0.08Q2 2026: $0.09Q3 2026: $0.14Forward: $0.72
Q2 2025: $-0.11Q3 2025: $-0.09Q4 2025: $-0.03Q1 2026: $0.08Q2 2026: $0.09Q3 2026: $0.14Forward: $0.72
QuarterTTM EPSYoY
Forward$0.72+414%
Q3 2026$0.14+$0.23
Q2 2026$0.09+$0.20

EQPT has the edge over RKLB in the latest year-over-year earnings comparison.

RKLB Earnings Per Share

Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
QuarterTTM EPSYoY
Q3 2026-$0.36+$0.03
Q2 2026-$0.27+$0.19
Q1 2026-$0.32+$0.09
Q4 2025-$0.37+$0.01
Q3 2025-$0.39-$0.02
Q2 2025-$0.46-$0.11
Q1 2025-$0.41-$0.04
Q4 2024-$0.38$0.00

RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.

EQPT Quarterly Revenue

Q1 2024: --Q2 2024: --Q3 2024: $776MQ4 2024: $1.6BQ1 2025: $716MQ2 2025: $1.1BQ3 2025: $944MQ4 2025: $1.6BQ1 2026: $989MQ2 2026: $1.4BQ3 2026: $1.5B
Q1 2024: --Q2 2024: --Q3 2024: $776MQ4 2024: $1.6BQ1 2025: $716MQ2 2025: $1.1BQ3 2025: $944MQ4 2025: $1.6BQ1 2026: $989MQ2 2026: $1.4BQ3 2026: $1.5B
QuarterRevenueYoY
Q3 2026$1.5B+56%
Q2 2026$1.4B+26%
Q1 2026$989M+38%
Q4 2025$1.6B+1.2%
Q3 2025$943.9M+22%

EQPT's revenue has grown year over year every quarter since late 2025: $1.5B last quarter, up 56% from the same quarter a year ago.

RKLB Quarterly Revenue

Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
QuarterRevenueYoY
Q3 2026$267.8M+73%
Q2 2026$234.1M+62%
Q1 2026$200.3M+63%
Q4 2025$179.7M+36%
Q3 2025$155.1M+48%
Q2 2025$144.5M+36%
Q1 2025$122.6M+32%
Q4 2024$132.4M+121%

RKLB has the edge over EQPT on sales, with stronger typical year-over-year growth.

EQPT Free Cash Flow

Q1 2024: −$266MQ2 2024: −$266MQ3 2024: −$270MQ4 2024: −$390MQ1 2025: −$404MQ2 2025: −$658MQ3 2025: −$476MQ4 2025: −$256MQ1 2026: −$576MQ2 2026: −$378MQ3 2026: −$37M
Q1 2024: −$266MQ2 2024: −$266MQ3 2024: −$270MQ4 2024: −$390MQ1 2025: −$404MQ2 2025: −$658MQ3 2025: −$476MQ4 2025: −$256MQ1 2026: −$576MQ2 2026: −$378MQ3 2026: −$37M
QuarterFree cash flowYoY
Q3 2026-$37M+$438.6M
Q2 2026-$378M+$280.1M
Q1 2026-$576M-$172M
Q4 2025-$256.1M+$134.2M
Q3 2025-$475.6M-$205.2M
Q2 2025-$658.1M-$391.9M
Q1 2025-$404M-$137.8M

EQPT has the edge over RKLB on cash flow, with more consistent year-over-year improvement.

RKLB Free Cash Flow

Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
QuarterFree cash flowYoY
Q3 2026-$23.9M+$45.5M
Q2 2026-$110.1M-$54.8M
Q1 2026-$77.4M+$5.5M
Q4 2025-$114.2M-$90.2M
Q3 2025-$69.4M-$27.5M
Q2 2025-$55.3M-$26.9M
Q1 2025-$82.9M-$61.1M
Q4 2024-$23.9M+$28.7M

RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.

EQPT Total Shares

Q3 2024: 251MQ4 2024: 251MQ1 2025: 251MQ2 2025: 251MQ3 2025: 251MQ4 2025: 251MQ1 2026: 253MQ2 2026: 253MQ3 2026: 254M
Q3 2024: 251MQ4 2024: 251MQ1 2025: 251MQ2 2025: 251MQ3 2025: 251MQ4 2025: 251MQ1 2026: 253MQ2 2026: 253MQ3 2026: 254M
PeriodChange %Net change
Quarterly+0.3%+740K shares
1 year+1%+2.5M shares

EQPT has the edge over RKLB on shareholder dilution, with a more favorable share count trend.

RKLB Total Shares

Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
PeriodChange %Net change
Quarterly+3.6%+22.6M shares
1 year+23%+124M shares
3 years+35%+168M shares
5 years+46%+204M shares

RKLB has 652M diluted shares, up 23% from a year ago.

EQPT Net Leverage

Q2 2025: 5.8xQ3 2025: 7.7xQ4 2025: 5.5xQ1 2026: 5.2xQ2 2026: 5.5xQ3 2026: 4.6x
Q2 2025: 5.8xQ3 2025: 7.7xQ4 2025: 5.5xQ1 2026: 5.2xQ2 2026: 5.5xQ3 2026: 4.6x
QuarterNet LeverageStatus
Q3 20264.6xHigh
Q2 20265.5xHigh
Q1 20265.2xHigh
Q4 20255.5xHigh
Q3 20257.7xHigh
Q2 20255.8xHigh

EQPT's net debt is about 4.6 years of its operating earnings (EBITDA), down from 7.7 years a year ago.

RKLB Net Leverage

RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

EQPT Weekly Momentum

MetricValueStatus
RSI40.1Neutral
Stochastic32.9Neutral

EQPT's weekly RSI is 40 (neutral) and its Stochastic is 33 (neutral).

RKLB Weekly Momentum

MetricValueStatus
RSI46.8Neutral
Stochastic27.6Neutral

RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).

EQPT PE vs Industrials Sector

MetricEQPTSector medianRelative
PE108x24x348% above

EQPT is trading at 108x earnings, a 348% premium to the Industrials sector's median of 24x, though its earnings don't support one.

RKLB PE vs Industrials Sector

RKLB has no meaningful PE right now: it lost money over the past year.

EQPT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$16.03.4% below
20 week MA$17.713% below

RKLB has stronger trend alignment. EQPT is above 0 of 2 weekly averages versus RKLB above 3 of 5.

RKLB Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$61.44.3% above
20 week MA$68.15.9% below
50 week MA$77.617% below
100 week MA$56.513% above
200 week MA$31.4104% above

RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.

EQPT Yearly ROI

YearStart priceEnd priceROI
2026 YTD$32.6$15.4-53%

It's down 53% so far in 2026.

RKLB Yearly ROI

YearStart priceEnd priceROI
2020$9.82$10.3+4.9%
2021$10.3$12.0+17%
2022$12.0$3.77-69%
2023$3.77$5.53+47%
2024$5.53$27.2+392%
2025$27.2$70.7+160%
2026 YTD$70.7$64.1-9.3%

RKLB has the edge over EQPT on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key